未登录

H

Hiromichi Dansako

Okayama University

H指数:28

被引数:2,551

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stem-like progenitor and terminally differentiated TFH-like CD4+T cell exhaustion in the tumor microenvironment

肿瘤微环境中的干细胞样祖细胞和终末分化的TFH样CD4 T细胞耗竭

IF6.9

2024-02-013

OA

Hepatitis C virus NS5B triggers an MDA5-mediated innate immune response by producing dsRNA without the replication of viral genomes

IF4.2

2023-10-272

OA

Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies

接受癌症免疫疗法治疗的晚期NSCLC患者颅内进展的低频率

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2023-08-232

OA

Combined treatment with direct hydrogen peroxide administration and irradiation promotes an abscopal effect in mouse models

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Extracellular vesicles activate ATM-Chk2 signaling pathway through the intercellular transfer of mitochondrial DNA in HBV-infected human hepatocytes

HBV感染的人肝细胞中，细胞外囊泡通过线粒体DNA的细胞间转移激活ATM-Chk2信号通路

IF4.2

2021-05-2711

PRE

Ribavirin-induced down-regulation of CCAAT/enhancer-binding protein a leads to suppression of lipogenesis

BIOCHEMICAL JOURNAL

IF4.3

2019-01-156

PREAI

Ribavirin Suppresses Hepatic Lipogenesis Through Inosine Monophosphate Dehydrogenase Inhibition: Involvement of Adenosine Monophosphate-Activated Protein Kinase-Related Kinases and Retinoid X Receptor α

HEPATOLOGY COMMUNICATIONS

IF4.6

2017-07-136

OAAI

The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly

循环gmp-amp合成酶-STING信号通路是针对HBV的先天免疫反应和HBV组装的抑制所必需的

IF4.2

2015-11-0975

OAAI

Negative regulation of hepatitis B virus replication by forkhead box protein A in human hepatoma cells

IF3

2015-03-3010

OAAI

Class A Scavenger Receptor 1 (MSR1) Restricts Hepatitis C Virus Replication by Mediating Toll-like Receptor 3 Recognition of Viral RNAs Produced in Neighboring Cells

IF4.9

2013-05-2367

OAAI

Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C

LIVER INTERNATIONAL

IF5.2

2011-06-077

PREAI

Amino acid substitutions of hepatitis C virus core protein are not associated with intracellular antiviral response to interferon-α in vitro

LIVER INTERNATIONAL

IF5.2

2010-06-299

PREAI

Oxidative Stress Induces Anti-Hepatitis C Virus Status via the Activation of Extracellular Signal-Regulated Kinase

IF15.8

2009-09-0142

OAAI

Development of a hepatitis C virus relapse model using genome-length hepatitis C virus ribonucleic acid-harboring cells possessing the interferon-α-resistance phenotype

HEPATOLOGY RESEARCH

IF3.4

2009-08-273

PREAI

Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-α

IF3

2009-03-2814

OA

Arsenic Trioxide Inhibits Hepatitis C Virus RNA Replication through Modulation of the Glutathione Redox System and Oxidative Stress

JOURNAL OF VIROLOGY

IF3.8

2009-03-0137

OAAI

The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication

JOURNAL OF VIROLOGY

IF3.8

2008-10-0167

OAAI

DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication

JOURNAL OF VIROLOGY

IF3.8

2007-12-15255

OAAI

Limited suppression of the interferon-β production by hepatitis C virus serine protease in cultured human hepatocytes

IF4.2

2007-07-2547

OAAI

Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2007-06-0173

OAAI